NeuroSense Therapeutics Ltd.
Institutional Ownership & Holdings Analysis
About
neurosense-therapeutics is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
| # | Institution | Value |
|---|---|---|
| 1 | CITADEL ADVISORS LLC(2024-12-31) | $304.8K |
| 2 | JANE STREET GROUP, LLC(2024-12-31) | $77.6K |
| 3 | HRT FINANCIAL LP(2024-12-31) | $77.0K |
| 4 | MORGAN STANLEY(2025-03-31) | $47.0K |
| 5 | MEITAV INVESTMENT HOUSE LTD(2025-03-31) | $37.2K |
| 6 | XTX Topco Ltd(2025-03-31) | $31.0K |
| 7 | Stratos Wealth Partners, LTD.(2024-12-31) | $24.0K |
| 8 | COMMONWEALTH EQUITY SERVICES, LLC(2025-03-31) | $16.0K |
| 9 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $14.6K |
| 10 | TWO SIGMA SECURITIES, LLC(2025-03-31) | $13.7K |
| 11 | Warberg Asset Management LLC(2025-03-31) | $9.9K |
| 12 | Hurley Capital, LLC(2025-03-31) | $8.1K |
| 13 | UBS Group AG(2025-03-31) | $2.1K |
| 14 | CWM, LLC(2025-03-31) | $1.0K |
| 15 | SBI Securities Co., Ltd.(2025-03-31) | $163 |
| 16 | CONCOURSE FINANCIAL GROUP SECURITIES, INC.(2025-03-31) | $0 |
As of 2024-12-31
Value:$304.8K
As of 2024-12-31
Value:$77.6K
As of 2024-12-31
Value:$77.0K
As of 2025-03-31
Value:$47.0K
As of 2025-03-31
Value:$37.2K
As of 2025-03-31
Value:$31.0K
As of 2024-12-31
Value:$24.0K
As of 2025-03-31
Value:$16.0K
As of 2025-03-31
Value:$14.6K
As of 2025-03-31
Value:$13.7K
As of 2025-03-31
Value:$9.9K
As of 2025-03-31
Value:$8.1K
#13UBS Group AG
As of 2025-03-31
Value:$2.1K
#14CWM, LLC
As of 2025-03-31
Value:$1.0K
As of 2025-03-31
Value:$163
As of 2025-03-31
Value:$0
Total Institutional Holders:16
Top 10 Holders Own:96.8%